Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-442-4 | CAS number: 106-92-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Carcinogenicity
Administrative data
Description of key information
It should be noted that these studies are not required at the prescribed level of registration, and are included as supporting information only. Presence of three rare neoplasms in the respiratory tract of male rats along with preneoplastic lesions at the site of the tumors suggests carcinogenic potential of Allyl Glycidyl Ether (AGE). Though, the biological significance of these tumors could not be assessed due to the lack of historical control data, the results are enough to classify AGE as “suspected human carcinogen”.
Key value for chemical safety assessment
Carcinogenicity: via inhalation route
Endpoint conclusion
- Dose descriptor:
- NOAEC
- 23.3 mg/m³
Justification for classification or non-classification
EU classification according to Annex VI of Directive 67/548/EEC: Cat 3/R40
CLP classification (EC No 1272/2008): Cat 2
Additional information
AGE was tested for its carcinogenic potential in 2 species (rats and mice; NTP, 1990).
Osborne-Mendel rats (50/sex/dose) were exposed to 0, 23.3 and 46.6 mg/m3 AGE vapors (6 hours/day, 5 days/week) for 103 weeks. Non-neoplastic lesions indicative of inflammation, degeneration and repair mechanisms were noted in both sexes in the olfactory and respiratory epithelium. In males at 46.6 mg/m3, 1 adenocarcinoma in the olfactory epithelium, 1 papillary adenoma and 1 squamous cell carcinoma in the respiratory epithelium were observed during histopathology examination. The fact that three different types of neoplasms originating from two different cell types without preneoplastic lesions were observed makes the treatment-relationship questionable. In addition, data interpretation was limited due to the absence of historical control data. Therefore, the carcinogenic potential in male rats was considered to be equivocal. No evidence of carcinogenic potential was found in females.
Similarly, B6C3F1 mice (50/sex/dose) were exposed to 0, 23.3 and 46.6 mg/m3 AGE vapors (6 hours/day, 5 days/week) for 102 weeks. Inflammation and degeneration of mucosa, olfactory and/or respiratory epithelium was observed. In three males and one female an adenoma of the respiratory epithelium was revealed at 46.6 mg/m3. Preneoplastic lesions were seen at the site of these adenomas. Although the incidence was not statistically significant, the rarity of these neoplasms in B6C3F1 mice suggests they were caused by AGE.
Taking data from both species into consideration, the biological significance of three neoplasms observed in the respiratory tract in male rats could not be assessed due to the lack of historical control data in this strain. The number of tumors in mice is limited, but the rarity of the neoplasms seen in this species and the presence of preneoplastic lesions at the site of the tumors suggests carcinogenic potential. While there is some uncertainty about the mechanism of tumor induction, it is likely that the genotoxic and irritant properties of this substance may play a role in tumourgenesis. Therefore, AGE is carcinogenic in rodents but the data does not support classification as a category 2 carcinogen. Thus, AGE should be classified in Cat 3/R40 based on EU standards and in Cat 2 based on GHS standards.
Carcinogenicity: via inhalation route (target organ): respiratory: nose
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.